REGENXBIO INC

Ticker: RGNX CUSIP: 75901B107 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 222,342 Value ($000) $1,825 Avg Close $8.37 Range $5.04 - $11.00
Q1 2025
Shares 225,580 Value ($000) $1,613 Avg Close $7.44 Range $5.62 - $9.06
Q2 2024
Shares 39,093 Value ($000) $457 Avg Close $15.56 Range $11.33 - $21.57
Q3 2023
Shares 33,249 Value ($000) $547 Avg Close $18.12 Range $16.14 - $20.38
Q4 2020
Shares 8,903 Value ($000) $404 Avg Close $34.94 Range $26.40 - $50.15
Q2 2020
Shares 58,445 Value ($000) $2,153 Avg Close $37.28 Range $27.42 - $45.06
Q1 2020
Shares 2,931 Value ($000) $95 Avg Close $41.66 Range $20.03 - $54.97
Q4 2018
Shares 38,821 Value ($000) $1,628 Avg Close $58.66 Range $38.56 - $77.48
Q3 2018
Shares 356,786 Value ($000) $26,937 Avg Close $72.05 Range $61.00 - $85.10
Q2 2018
Shares 205,049 Value ($000) $14,712 Avg Close $47.76 Range $26.80 - $75.15